S-Bank Fund Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19M Sell
15,834
-4,704
-23% -$4.81M 2.58% 8
2026
Q1
$18.9M Sell
20,538
-9,317
-31% -$9.45M 2.81% 6
2025
Q4
$32.1M Buy
29,855
+2,077
+7% +$1.99M 4.16% 5
2025
Q3
$21.2M Buy
27,778
+7,846
+39% +$5.84M 2.81% 6
2025
Q2
$15.5M Buy
19,932
+10,527
+112% +$8.18M 2.29% 7
2025
Q1
$7.77M Buy
+9,405
New +$7.83M 1.46% 15

Other funds holding LLY

S-Bank Fund Management's LLY Position: Q2 2026 in Review

S-Bank Fund Management reduced its Eli Lilly (LLY) stake by 23% in Q2 2026, selling an estimated $4.81M and leaving 15,834 shares worth $19M. The position accounts for 2.58% of the portfolio, ranked #8.

S-Bank Fund Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $32.1M in Q4 2025. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • S-Bank Fund Management held 15,834 shares of Eli Lilly worth $19M as of Q2 2026.
  • S-Bank Fund Management sold 4,704 Eli Lilly shares in Q2 2026, an estimated $4.81M.
  • Eli Lilly made up 2.58% of S-Bank Fund Management's portfolio in Q2 2026, its #8 holding.
  • S-Bank Fund Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • S-Bank Fund Management's Eli Lilly position peaked at $32.1M in Q4 2025.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.